Article info

Original article
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice
Free

Authors

  1. Correspondence to Dr John D Campbell, Dynavax Technologies, 2929 7th St, Ste 100, Berkeley, CA 94710, USA; dcampbell{at}dynavax.com
View Full Text

Citation

Campbell JD, Kell SA, Kozy HM, et al
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice

Publication history

  • Received October 3, 2013
  • Revised December 24, 2013
  • Accepted January 9, 2014
  • First published January 24, 2014.
Online issue publication 
May 14, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.